With the pace of novel immuno-oncology therapeutics, drug developers are seeking urgent help in more advanced, predictive tumour models for preclinical analysis to continue progressing pipelines and empowering clinical success.
While technology has matured, and our disease biology understanding has improved, there is still a huge gap between translational and clinical readouts.
Our Tumour Models community members are eager to partner with model developers & CROs, RNA-sequencers, imaging experts, 3D bioprinting enthusiasts, immunoassay specialists and bioinformatic software champions who can help them invigorate their drug discovery and development with confidence.
As the most well-established and longest-running community, the 11th Annual Tumour Models London will return this December.
After 2 years of virtual meeting, this is your opportunity to reconnect with your fellow colleagues face-to-face, expand your network with key preclinical and translational decision-makers across the UK and Europe.
As the only industry-led meeting focusing specifically on immuno-oncology tumour model utility, you can develop strategic relationships, gain market insight, network with 100+ thought-leaders and showcase your expertise to affirm your position as a leader in preclinical oncology.
Can your platform or service help boost their clinical confidence to provide predictive data and ultimately help them get the best medicine to the patient? If so, we would love to hear from you!
Get in touch with Adam Mayer our partnerships director to find out more.
Engage, network, and foster your long-term relationships with Preclinical Immuno-Oncology Leaders from pharma majors and biotechs
Showcase your pioneering solutions and expertise to differentiate yourself from other service providers in front of our expertly selected audience
Assess the latest market intelligence to align your services with your customers' needs
Gain invaluable insight to where the markets developing needs are, thereby allowing you to
Attendees by Seniority
Attendees by Company Type